Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines

Abstract : Histone deacetylases (HDACs) are well-established, promising targets for anticancer therapy due to their critical role in cancer development. Accordingly, an increasing number of HDAC inhibitors displaying cytotoxic effects against cancer cells have been reported. Among them, a large panel of chemical structures was described including coumarin-containing molecules. In this study, we described synthesis and biological activity of new coumarin-based derivatives as HDAC inhibitors. Among eight derivatives, three compounds showed HDAC inhibitory activities and antitumor activities against leukemia cell lines without affecting the viability of peripheral blood mononuclear cells from healthy donors.
Type de document :
Article dans une revue
Bioorganic & Medicinal Chemistry Letters, Elsevier, 2014, 24 (16), pp.3797 - 3801. 〈10.1016/j.bmcl.2014.06.067〉
Domaine :
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01494600
Contributeur : Srsmc Ul <>
Soumis le : jeudi 23 mars 2017 - 16:42:39
Dernière modification le : jeudi 20 septembre 2018 - 01:07:58

Identifiants

Collections

Citation

Carole Seidel, Michael Schnekenburger, Clemens Zwergel, François Gaascht, Antonello Mai, et al.. Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines. Bioorganic & Medicinal Chemistry Letters, Elsevier, 2014, 24 (16), pp.3797 - 3801. 〈10.1016/j.bmcl.2014.06.067〉. 〈hal-01494600〉

Partager

Métriques

Consultations de la notice

59